Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis.
Manon BelhassenFaustine DalonMaëva NolinEric Van GansePublished in: Respiratory research (2021)
This observational study identified potential differences in outcome under newly prescribed antifibrotic drugs, deserving further explorations.